Related Experiment Videos
C-19393 E5, a new carbapenem antibiotic. Fermentation, isolation and structure
The Journal of Antibiotics
|August 1, 1982
Summary
A novel carbapenem antibiotic, C-19393 E5, was discovered from Streptomyces griseus. This new antibiotic exhibits broad-spectrum antimicrobial activity and potent beta-lactamase inhibition.
Area of Science:
- Microbiology
- Medicinal Chemistry
- Pharmacology
Background:
- Carbapenem antibiotics are crucial for treating bacterial infections.
- Development of new carbapenems is essential due to rising antimicrobial resistance.
- Streptomyces species are a known source of novel antibiotics.
Purpose of the Study:
- To isolate and characterize a new carbapenem antibiotic, C-19393 E5.
- To determine the chemical structure of C-19393 E5.
- To evaluate the antimicrobial spectrum and beta-lactamase inhibitory activity of C-19393 E5.
Main Methods:
- Isolation of C-19393 E5 from Streptomyces griseus subsp. cryophilus C-19393 culture filtrate.
- Structural elucidation using spectral data comparison with known carbapenems.
- Confirmation of structure via partial synthesis from epithienamycin B.
Main Results:
- C-19393 E5 was identified as a minor component from the bacterial culture.
- The chemical structure was determined and confirmed through synthesis.
- The antibiotic demonstrated a broad antimicrobial spectrum.
- Significant inhibitory activity against beta-lactamases was observed.
Conclusions:
- C-19393 E5 represents a promising new carbapenem antibiotic.
- Its structural features contribute to its broad-spectrum activity and beta-lactamase stability.
- Further investigation into C-19393 E5 is warranted for potential therapeutic applications.